 |
PDBsum entry 5k5m
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.3.4.21.91
- flavivirin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Selective hydrolysis of Xaa-Xaa-|-Xbb bonds in which each of the Xaa can be either Arg or Lys and Xbb can be either Ser or Ala.
|
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.6.1.15
- nucleoside-triphosphate phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
|
 |
 |
 |
 |
 |
ribonucleoside 5'-triphosphate
|
+
|
H2O
|
=
|
ribonucleoside 5'-diphosphate
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.3.6.4.13
- Rna helicase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O = ADP + phosphate + H+
|
 |
 |
 |
 |
 |
ATP
|
+
|
H2O
|
=
|
ADP
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Plos Pathog
12:e1005737
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling.
|
|
S.P.Lim,
C.G.Noble,
C.C.Seh,
T.S.Soh,
A.El Sahili,
G.K.Chan,
J.Lescar,
R.Arora,
T.Benson,
S.Nilar,
U.Manjunatha,
K.F.Wan,
H.Dong,
X.Xie,
P.Y.Shi,
F.Yokokawa.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Flaviviruses comprise major emerging pathogens such as dengue virus (DENV) or
Zika virus (ZIKV). The flavivirus RNA genome is replicated by the
RNA-dependent-RNA polymerase (RdRp) domain of non-structural protein 5 (NS5).
This essential enzymatic activity renders the RdRp attractive for antiviral
therapy. NS5 synthesizes viral RNA via a "de novo" initiation
mechanism. Crystal structures of the flavivirus RdRp revealed a
"closed" conformation reminiscent of a pre-initiation state, with a
well ordered priming loop that extrudes from the thumb subdomain into the dsRNA
exit tunnel, close to the "GDD" active site. To-date, no allosteric
pockets have been identified for the RdRp, and compound screening campaigns did
not yield suitable drug candidates. Using fragment-based screening via X-ray
crystallography, we found a fragment that bound to a pocket of the apo-DENV RdRp
close to its active site (termed "N pocket"). Structure-guided
improvements yielded DENV pan-serotype inhibitors of the RdRp de novo initiation
activity with nano-molar potency that also impeded elongation activity at
micro-molar concentrations. Inhibitors exhibited mixed inhibition kinetics with
respect to competition with the RNA or GTP substrate. The best compounds have
EC50 values of 1-2 μM against all four DENV serotypes in cell culture assays.
Genome-sequencing of compound-resistant DENV replicons, identified amino acid
changes that mapped to the N pocket. Since inhibitors bind at the thumb/palm
interface of the RdRp, this class of compounds is proposed to hinder RdRp
conformational changes during its transition from initiation to elongation. This
is the first report of a class of pan-serotype and cell-active DENV RdRp
inhibitors. Given the evolutionary conservation of residues lining the N pocket,
these molecules offer insights to treat other serious conditions caused by
flaviviruses.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |